Youths receiving dual therapy for depression had the highest incidence of attempted suicide compared with those receiving monotherapy.
A majority of study participants also reported that they frequently skip doses of ADHD medication.
Antidepressant discontinuation increased the odds of relapse compared with continued therapy.
Increases were greatest among women, older adults, racial/ethnic minorities, and individuals with lower educational level and family income.
The number of physicians adopting buprenorphine therapy has not kept pace with the magnitude of the opioid epidemic.
Researchers sought to examine the link between intelligence scores during childhood and leading causes of death during the life course.
Results from a 27-year follow-up study found no association between physical activity and a lower risk of dementia.
Patients exhibiting moderate-to-severe depressive symptoms had worse adherence than nondepressed patients.
A recent survey found that 26% of workers felt tense or stressed ever since the election, due to political discussions at work.
Substance use is associated with an increased risk of adolescent firearm homicide.
Patients diagnosed with a prior psychiatric condition have increased odds of long-term opioid receipt than patients without these conditions.
Two studies found that psilocybin (magic mushrooms) treatment was effective for anxiety and depression.
Electroconvulsive therapy is effective for depression in patients with suicidal ideation and resistance to other treatments.
Most young children with an emotional, behavioral, or relationship problem receive no interventions for their disorder.
The prevalence of dementia dropped about 24% between 2000 and 2012.
Older adults with depression are less likely to adhere to COPD maintenance medications regimens.
While many suicide prevention techniques are effective, others have not been proven to be beneficial.
For children and teens diagnosed with depression, the benefits of the most commonly prescribed antidepressants may not outweigh the risks.
Probuphine is the first buprenorphine implant approved for the maintenance treatment of opioid dependence.
Mothers who heavily used tobacco during pregnancy increased the risk of their children developing schizophrenia.
Antidepressant use for anxiety, panic, and ADHD has increased.
Since 2002, the number of hospitalizations due to opioid abuse and dependence has increased by 72%.
Low dose lithium can bring return absolute neutrophil count (ANC) to normal levels.
Young adults with sleep problems have increased risks of developing chronic pain and experiencing worsening in pain severity.
A large study found that use of SSRI medications to treat depression does not increase the risk of cardiovascular events in patients 20 to 64 years of age.
Women considered obese were more likely to have depression than women of a normal weight.
Researchers saw improvement in 80% of patients treated with ketamine infusion therapy.
The rate of misuse of prescription stimulants has risen among young adults despite the rate of prescriptions remaining the same.
The USPSTF has found insufficient evidence to support screening all young children for autism spectrum disorder if a parent or clinician has no expressed concerns.
Patients administered low doses of benzodiazepines have an elevated risk of dementia and Alzheimer's disease compared with patients who received higher doses.